| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Mutation | 40 | 2024 | 132 | 3.810 |
Why?
|
| Retinitis Pigmentosa | 8 | 2024 | 8 | 3.430 |
Why?
|
| Phenotype | 30 | 2024 | 148 | 3.100 |
Why?
|
| Eye Diseases, Hereditary | 7 | 2024 | 7 | 3.040 |
Why?
|
| Retina | 21 | 2024 | 25 | 2.970 |
Why?
|
| Retinal Diseases | 9 | 2024 | 16 | 2.890 |
Why?
|
| Pedigree | 32 | 2024 | 58 | 2.270 |
Why?
|
| Usher Syndromes | 8 | 2024 | 8 | 2.250 |
Why?
|
| Animals | 37 | 2024 | 261 | 2.210 |
Why?
|
| Microphthalmos | 9 | 2024 | 9 | 2.130 |
Why?
|
| Nerve Tissue Proteins | 8 | 2022 | 21 | 1.970 |
Why?
|
| Humans | 99 | 2024 | 18430 | 1.880 |
Why?
|
| Coloboma | 9 | 2024 | 9 | 1.820 |
Why?
|
| Membrane Proteins | 5 | 2020 | 40 | 1.810 |
Why?
|
| Retinal Dystrophies | 5 | 2024 | 5 | 1.720 |
Why?
|
| Mutation, Missense | 9 | 2024 | 21 | 1.650 |
Why?
|
| Tomography, Optical Coherence | 15 | 2024 | 15 | 1.580 |
Why?
|
| Retinal Degeneration | 10 | 2022 | 10 | 1.520 |
Why?
|
| Genetic Predisposition to Disease | 11 | 2024 | 414 | 1.450 |
Why?
|
| Genetic Therapy | 4 | 2020 | 8 | 1.450 |
Why?
|
| Retinoschisis | 4 | 2023 | 4 | 1.410 |
Why?
|
| Macular Degeneration | 4 | 2023 | 19 | 1.390 |
Why?
|
| Genetic Association Studies | 9 | 2023 | 35 | 1.360 |
Why?
|
| Abnormalities, Multiple | 5 | 2021 | 11 | 1.310 |
Why?
|
| Intellectual Disability | 6 | 2021 | 27 | 1.300 |
Why?
|
| Mice | 20 | 2024 | 68 | 1.290 |
Why?
|
| Male | 49 | 2024 | 10440 | 1.190 |
Why?
|
| Cone-Rod Dystrophies | 6 | 2023 | 6 | 1.180 |
Why?
|
| Female | 50 | 2024 | 13136 | 1.170 |
Why?
|
| Basic Helix-Loop-Helix Transcription Factors | 4 | 2013 | 9 | 1.160 |
Why?
|
| Hearing Loss, Sensorineural | 3 | 2023 | 7 | 1.150 |
Why?
|
| Craniofacial Abnormalities | 5 | 2021 | 7 | 1.050 |
Why?
|
| Eye Proteins | 10 | 2023 | 13 | 1.040 |
Why?
|
| Aniridia | 2 | 2022 | 2 | 1.040 |
Why?
|
| Vitelliform Macular Dystrophy | 2 | 2022 | 2 | 0.980 |
Why?
|
| Ophthalmology | 3 | 2020 | 6 | 0.970 |
Why?
|
| Choroideremia | 2 | 2022 | 2 | 0.950 |
Why?
|
| Child | 27 | 2024 | 2571 | 0.940 |
Why?
|
| Cataract | 2 | 2022 | 10 | 0.940 |
Why?
|
| Hyperopia | 2 | 2020 | 2 | 0.920 |
Why?
|
| Amelogenesis Imperfecta | 2 | 2020 | 2 | 0.920 |
Why?
|
| Peripherins | 2 | 2020 | 2 | 0.920 |
Why?
|
| Visual Acuity | 11 | 2022 | 22 | 0.910 |
Why?
|
| Limb Deformities, Congenital | 2 | 2021 | 2 | 0.910 |
Why?
|
| Gene Expression Regulation, Developmental | 7 | 2022 | 7 | 0.900 |
Why?
|
| Homeodomain Proteins | 5 | 2022 | 16 | 0.890 |
Why?
|
| Frameshift Mutation | 3 | 2022 | 4 | 0.840 |
Why?
|
| Choroidal Neovascularization | 1 | 2022 | 1 | 0.840 |
Why?
|
| Bestrophins | 2 | 2022 | 2 | 0.830 |
Why?
|
| Genes, X-Linked | 1 | 2022 | 2 | 0.830 |
Why?
|
| Extracellular Matrix Proteins | 5 | 2022 | 6 | 0.820 |
Why?
|
| Eye Abnormalities | 1 | 2022 | 1 | 0.820 |
Why?
|
| Color Vision Defects | 5 | 2021 | 5 | 0.810 |
Why?
|
| Heart Defects, Congenital | 1 | 2022 | 37 | 0.800 |
Why?
|
| ATPases Associated with Diverse Cellular Activities | 2 | 2021 | 3 | 0.790 |
Why?
|
| Young Adult | 20 | 2024 | 2518 | 0.790 |
Why?
|
| Ectodermal Dysplasia | 1 | 2021 | 1 | 0.780 |
Why?
|
| Alleles | 8 | 2024 | 95 | 0.770 |
Why?
|
| Adult | 29 | 2024 | 7910 | 0.760 |
Why?
|
| ATP-Binding Cassette Transporters | 6 | 2023 | 9 | 0.760 |
Why?
|
| Serine Proteases | 1 | 2020 | 1 | 0.750 |
Why?
|
| Peroxisomal Disorders | 1 | 2020 | 1 | 0.740 |
Why?
|
| Nails, Malformed | 1 | 2020 | 2 | 0.740 |
Why?
|
| Carboxylic Ester Hydrolases | 2 | 2024 | 2 | 0.740 |
Why?
|
| Eye Diseases | 1 | 2020 | 6 | 0.740 |
Why?
|
| Child, Preschool | 18 | 2022 | 1478 | 0.720 |
Why?
|
| Face | 2 | 2020 | 5 | 0.720 |
Why?
|
| Adolescent | 20 | 2024 | 3798 | 0.700 |
Why?
|
| Electroretinography | 11 | 2024 | 11 | 0.680 |
Why?
|
| Infant | 16 | 2024 | 1245 | 0.670 |
Why?
|
| Neurogenesis | 3 | 2019 | 5 | 0.640 |
Why?
|
| Genetic Variation | 5 | 2021 | 87 | 0.610 |
Why?
|
| Zebrafish | 9 | 2022 | 9 | 0.580 |
Why?
|
| Retinal Cone Photoreceptor Cells | 7 | 2023 | 7 | 0.570 |
Why?
|
| DNA-Binding Proteins | 4 | 2020 | 31 | 0.560 |
Why?
|
| Eye | 3 | 2022 | 3 | 0.560 |
Why?
|
| Gene Deletion | 2 | 2015 | 3 | 0.560 |
Why?
|
| Hearing Loss | 5 | 2023 | 15 | 0.520 |
Why?
|
| Transcription Factors | 5 | 2024 | 20 | 0.500 |
Why?
|
| Blepharoptosis | 1 | 2014 | 1 | 0.500 |
Why?
|
| Dwarfism | 1 | 2014 | 1 | 0.500 |
Why?
|
| Hypertrichosis | 1 | 2014 | 1 | 0.500 |
Why?
|
| Laurence-Moon Syndrome | 1 | 2014 | 1 | 0.500 |
Why?
|
| Brain | 3 | 2020 | 46 | 0.500 |
Why?
|
| Developmental Disabilities | 5 | 2021 | 53 | 0.500 |
Why?
|
| Middle Aged | 19 | 2024 | 8284 | 0.490 |
Why?
|
| Cell Lineage | 2 | 2019 | 2 | 0.480 |
Why?
|
| Visual Fields | 3 | 2023 | 4 | 0.450 |
Why?
|
| Retinal Ganglion Cells | 3 | 2017 | 5 | 0.450 |
Why?
|
| Cell Cycle | 1 | 2013 | 4 | 0.440 |
Why?
|
| Hereditary Autoinflammatory Diseases | 2 | 2022 | 2 | 0.430 |
Why?
|
| Anophthalmos | 2 | 2024 | 2 | 0.430 |
Why?
|
| Leber Congenital Amaurosis | 1 | 2012 | 1 | 0.420 |
Why?
|
| High-Throughput Nucleotide Sequencing | 6 | 2024 | 13 | 0.410 |
Why?
|
| DNA Mutational Analysis | 6 | 2024 | 21 | 0.400 |
Why?
|
| Mitochondria | 2 | 2024 | 4 | 0.400 |
Why?
|
| Registries | 3 | 2024 | 490 | 0.390 |
Why?
|
| Introns | 2 | 2022 | 10 | 0.380 |
Why?
|
| Optic Atrophy, Autosomal Dominant | 2 | 2024 | 2 | 0.380 |
Why?
|
| Kearns-Sayre Syndrome | 2 | 2020 | 2 | 0.370 |
Why?
|
| Infant, Newborn | 7 | 2024 | 872 | 0.370 |
Why?
|
| Phospholipases | 2 | 2024 | 2 | 0.370 |
Why?
|
| Deafness | 2 | 2023 | 5 | 0.360 |
Why?
|
| Heterozygote | 4 | 2022 | 29 | 0.340 |
Why?
|
| Syndrome | 6 | 2022 | 29 | 0.340 |
Why?
|
| Genotype | 8 | 2023 | 253 | 0.330 |
Why?
|
| Nervous System Diseases | 2 | 2022 | 20 | 0.320 |
Why?
|
| Osteochondrodysplasias | 2 | 2020 | 2 | 0.320 |
Why?
|
| Vision Disorders | 4 | 2023 | 18 | 0.320 |
Why?
|
| Retinal Pigment Epithelium | 4 | 2022 | 4 | 0.310 |
Why?
|
| Cadherins | 3 | 2023 | 6 | 0.310 |
Why?
|
| Disease Models, Animal | 4 | 2024 | 19 | 0.300 |
Why?
|
| Myopia | 3 | 2023 | 10 | 0.290 |
Why?
|
| Fovea Centralis | 2 | 2023 | 2 | 0.290 |
Why?
|
| Premature Birth | 2 | 2022 | 138 | 0.290 |
Why?
|
| Mitochondrial Proteins | 2 | 2017 | 2 | 0.280 |
Why?
|
| Phosphate Transport Proteins | 2 | 2017 | 2 | 0.280 |
Why?
|
| Exons | 3 | 2024 | 10 | 0.280 |
Why?
|
| Mosaicism | 3 | 2021 | 3 | 0.270 |
Why?
|
| NF-kappa B | 2 | 2022 | 11 | 0.260 |
Why?
|
| Cadherin Related Proteins | 2 | 2022 | 2 | 0.260 |
Why?
|
| Genetic Testing | 3 | 2021 | 89 | 0.260 |
Why?
|
| Mandibulofacial Dysostosis | 2 | 2015 | 2 | 0.250 |
Why?
|
| Rod Opsins | 2 | 2016 | 2 | 0.250 |
Why?
|
| Visual Field Tests | 5 | 2023 | 5 | 0.250 |
Why?
|
| Oligonucleotides, Antisense | 1 | 2024 | 1 | 0.250 |
Why?
|
| GTP Phosphohydrolases | 1 | 2024 | 1 | 0.250 |
Why?
|
| Macaca fascicularis | 1 | 2024 | 3 | 0.250 |
Why?
|
| Acyltransferases | 1 | 2024 | 1 | 0.240 |
Why?
|
| Genomics | 2 | 2024 | 66 | 0.240 |
Why?
|
| RNA-Binding Proteins | 2 | 2022 | 6 | 0.230 |
Why?
|
| Mice, Inbred C57BL | 4 | 2019 | 17 | 0.230 |
Why?
|
| Fluorescein Angiography | 5 | 2022 | 7 | 0.220 |
Why?
|
| Genetic Diseases, X-Linked | 3 | 2022 | 3 | 0.220 |
Why?
|
| Myopia, Degenerative | 1 | 2023 | 1 | 0.220 |
Why?
|
| Renal Insufficiency | 1 | 2023 | 13 | 0.220 |
Why?
|
| Spinocerebellar Ataxias | 1 | 2022 | 1 | 0.220 |
Why?
|
| Klinefelter Syndrome | 1 | 2022 | 2 | 0.220 |
Why?
|
| Hypogonadism | 1 | 2022 | 4 | 0.220 |
Why?
|
| Hypohidrosis | 1 | 2022 | 1 | 0.220 |
Why?
|
| Macular Edema | 1 | 2022 | 1 | 0.220 |
Why?
|
| Neuropeptides | 1 | 2022 | 2 | 0.220 |
Why?
|
| Indocyanine Green | 1 | 2022 | 1 | 0.210 |
Why?
|
| Retinal Detachment | 1 | 2022 | 1 | 0.210 |
Why?
|
| Protein Kinases | 1 | 2022 | 1 | 0.210 |
Why?
|
| Tissue Inhibitor of Metalloproteinase-3 | 1 | 2022 | 1 | 0.210 |
Why?
|
| Protein Sorting Signals | 1 | 2022 | 1 | 0.210 |
Why?
|
| Williams Syndrome | 1 | 2022 | 1 | 0.210 |
Why?
|
| Aortic Stenosis, Supravalvular | 1 | 2022 | 1 | 0.210 |
Why?
|
| Point Mutation | 2 | 2019 | 6 | 0.210 |
Why?
|
| Vision, Ocular | 1 | 2022 | 2 | 0.210 |
Why?
|
| Founder Effect | 1 | 2022 | 1 | 0.210 |
Why?
|
| Arabs | 1 | 2022 | 2 | 0.210 |
Why?
|
| Forkhead Transcription Factors | 1 | 2022 | 6 | 0.210 |
Why?
|
| Photoreceptor Cells, Vertebrate | 1 | 2022 | 1 | 0.200 |
Why?
|
| Bone Diseases, Developmental | 2 | 2019 | 2 | 0.200 |
Why?
|
| AMP-Activated Protein Kinases | 1 | 2021 | 2 | 0.200 |
Why?
|
| Homozygote | 5 | 2020 | 14 | 0.200 |
Why?
|
| Protein Precursors | 1 | 2021 | 5 | 0.200 |
Why?
|
| Dystonia | 1 | 2021 | 1 | 0.200 |
Why?
|
| Spastic Paraplegia, Hereditary | 1 | 2021 | 1 | 0.200 |
Why?
|
| Dystonic Disorders | 1 | 2021 | 1 | 0.200 |
Why?
|
| Muscle Spasticity | 1 | 2021 | 1 | 0.200 |
Why?
|
| Image Processing, Computer-Assisted | 1 | 2021 | 11 | 0.200 |
Why?
|
| Epilepsy | 1 | 2021 | 13 | 0.200 |
Why?
|
| Cerebral Palsy | 1 | 2021 | 12 | 0.200 |
Why?
|
| Choroid | 4 | 2022 | 4 | 0.200 |
Why?
|
| Transcriptome | 1 | 2021 | 22 | 0.200 |
Why?
|
| DNA | 1 | 2021 | 25 | 0.200 |
Why?
|
| Optic Disk | 1 | 2021 | 1 | 0.200 |
Why?
|
| Alagille Syndrome | 1 | 2021 | 1 | 0.200 |
Why?
|
| Ubiquitin-Activating Enzymes | 1 | 2021 | 1 | 0.200 |
Why?
|
| Electrooculography | 1 | 2021 | 1 | 0.190 |
Why?
|
| Genetics | 1 | 2021 | 2 | 0.190 |
Why?
|
| Gene Expression Regulation | 2 | 2018 | 23 | 0.190 |
Why?
|
| Histone Acetyltransferases | 2 | 2024 | 2 | 0.190 |
Why?
|
| Sex Chromosome Disorders | 1 | 2021 | 1 | 0.190 |
Why?
|
| SOXB1 Transcription Factors | 1 | 2021 | 1 | 0.190 |
Why?
|
| Odontodysplasia | 1 | 2021 | 1 | 0.190 |
Why?
|
| Meta-Analysis as Topic | 1 | 2021 | 35 | 0.190 |
Why?
|
| Exanthema | 1 | 2021 | 8 | 0.190 |
Why?
|
| Drosophila | 1 | 2020 | 1 | 0.190 |
Why?
|
| Drosophila Proteins | 1 | 2020 | 1 | 0.190 |
Why?
|
| Cleft Lip | 1 | 2020 | 5 | 0.190 |
Why?
|
| Cleft Palate | 1 | 2020 | 7 | 0.190 |
Why?
|
| Glaucoma, Open-Angle | 1 | 2021 | 10 | 0.190 |
Why?
|
| Cyclic Nucleotide Phosphodiesterases, Type 6 | 1 | 2020 | 1 | 0.190 |
Why?
|
| Hand Deformities, Congenital | 1 | 2020 | 1 | 0.190 |
Why?
|
| Micrognathism | 1 | 2020 | 1 | 0.190 |
Why?
|
| Neck | 1 | 2020 | 3 | 0.190 |
Why?
|
| Adaptor Proteins, Signal Transducing | 1 | 2020 | 15 | 0.190 |
Why?
|
| Dysostoses | 1 | 2020 | 1 | 0.180 |
Why?
|
| Ichthyosis | 1 | 2020 | 1 | 0.180 |
Why?
|
| Nervous System Malformations | 1 | 2020 | 1 | 0.180 |
Why?
|
| Phosphoprotein Phosphatases | 1 | 2020 | 1 | 0.180 |
Why?
|
| Cerebellum | 1 | 2020 | 2 | 0.180 |
Why?
|
| Acetyltransferases | 1 | 2020 | 1 | 0.180 |
Why?
|
| Mucopolysaccharidosis III | 1 | 2020 | 1 | 0.180 |
Why?
|
| Calcium-Binding Proteins | 1 | 2020 | 3 | 0.180 |
Why?
|
| Genome, Human | 1 | 2020 | 42 | 0.180 |
Why?
|
| Anterior Eye Segment | 1 | 2020 | 1 | 0.180 |
Why?
|
| Uvea | 1 | 2020 | 1 | 0.180 |
Why?
|
| Posterior Eye Segment | 1 | 2020 | 1 | 0.180 |
Why?
|
| Rare Diseases | 1 | 2020 | 1 | 0.180 |
Why?
|
| Chromosome Aberrations | 1 | 2020 | 7 | 0.180 |
Why?
|
| Genetic Counseling | 1 | 2020 | 35 | 0.180 |
Why?
|
| Codon, Nonsense | 2 | 2017 | 2 | 0.180 |
Why?
|
| Precision Medicine | 1 | 2020 | 29 | 0.180 |
Why?
|
| Uniparental Disomy | 1 | 2020 | 1 | 0.180 |
Why?
|
| Cation Transport Proteins | 1 | 2020 | 2 | 0.180 |
Why?
|
| Protein Interaction Domains and Motifs | 1 | 2019 | 1 | 0.180 |
Why?
|
| Receptors, Retinoic Acid | 1 | 2019 | 2 | 0.180 |
Why?
|
| Genes, Recessive | 1 | 2019 | 1 | 0.180 |
Why?
|
| ADP-Ribosylation Factors | 1 | 2019 | 1 | 0.180 |
Why?
|
| Pseudogenes | 1 | 2019 | 1 | 0.170 |
Why?
|
| Cyclic Nucleotide-Gated Cation Channels | 1 | 2019 | 1 | 0.170 |
Why?
|
| Synaptic Transmission | 1 | 2019 | 2 | 0.170 |
Why?
|
| Cartilage | 1 | 2019 | 1 | 0.170 |
Why?
|
| Intestinal Polyposis | 1 | 2019 | 1 | 0.170 |
Why?
|
| Bone Morphogenetic Protein Receptors, Type I | 1 | 2019 | 1 | 0.170 |
Why?
|
| Muscular Atrophy | 1 | 2019 | 2 | 0.170 |
Why?
|
| Arthrogryposis | 1 | 2019 | 1 | 0.170 |
Why?
|
| Sphingomyelin Phosphodiesterase | 1 | 2019 | 1 | 0.170 |
Why?
|
| Microcephaly | 1 | 2019 | 3 | 0.170 |
Why?
|
| Neoplastic Syndromes, Hereditary | 1 | 2019 | 7 | 0.170 |
Why?
|
| Neurodevelopmental Disorders | 1 | 2019 | 7 | 0.170 |
Why?
|
| Spasms, Infantile | 2 | 2022 | 2 | 0.170 |
Why?
|
| Blindness | 2 | 2022 | 5 | 0.170 |
Why?
|
| Exome | 5 | 2017 | 25 | 0.170 |
Why?
|
| Glaucoma, Angle-Closure | 1 | 2019 | 2 | 0.170 |
Why?
|
| Musculoskeletal Abnormalities | 2 | 2020 | 3 | 0.170 |
Why?
|
| Gene Expression | 4 | 2020 | 23 | 0.170 |
Why?
|
| Green Fluorescent Proteins | 2 | 2010 | 2 | 0.160 |
Why?
|
| Neuroectodermal Tumors, Primitive | 1 | 2018 | 1 | 0.160 |
Why?
|
| Ribonuclease III | 1 | 2018 | 1 | 0.160 |
Why?
|
| DEAD-box RNA Helicases | 1 | 2018 | 1 | 0.160 |
Why?
|
| Ciliary Body | 1 | 2018 | 2 | 0.160 |
Why?
|
| Uveal Neoplasms | 1 | 2018 | 3 | 0.160 |
Why?
|
| Organ Specificity | 1 | 2018 | 4 | 0.160 |
Why?
|
| Amino Acid Sequence | 2 | 2015 | 9 | 0.160 |
Why?
|
| Gene Expression Regulation, Neoplastic | 1 | 2018 | 55 | 0.160 |
Why?
|
| Molecular Sequence Data | 2 | 2015 | 18 | 0.160 |
Why?
|
| Magnetic Resonance Imaging | 2 | 2017 | 105 | 0.160 |
Why?
|
| Autistic Disorder | 1 | 2019 | 105 | 0.150 |
Why?
|
| Protein Binding | 3 | 2020 | 9 | 0.150 |
Why?
|
| Aged | 4 | 2024 | 6417 | 0.150 |
Why?
|
| Cohort Studies | 2 | 2022 | 2672 | 0.150 |
Why?
|
| Holoprosencephaly | 1 | 2017 | 5 | 0.150 |
Why?
|
| Disease Progression | 4 | 2022 | 271 | 0.150 |
Why?
|
| Macula Lutea | 1 | 2017 | 2 | 0.150 |
Why?
|
| Hermanski-Pudlak Syndrome | 1 | 2017 | 1 | 0.150 |
Why?
|
| Dystrophin-Associated Proteins | 1 | 2017 | 1 | 0.150 |
Why?
|
| Telemedicine | 1 | 2020 | 184 | 0.150 |
Why?
|
| Albinism | 1 | 2016 | 1 | 0.140 |
Why?
|
| Osteopetrosis | 1 | 2016 | 1 | 0.140 |
Why?
|
| Microphthalmia-Associated Transcription Factor | 1 | 2016 | 1 | 0.140 |
Why?
|
| Megalencephaly | 1 | 2016 | 2 | 0.140 |
Why?
|
| Sequence Analysis, DNA | 4 | 2018 | 38 | 0.140 |
Why?
|
| Smoothened Receptor | 1 | 2016 | 1 | 0.140 |
Why?
|
| Skin Abnormalities | 1 | 2016 | 1 | 0.140 |
Why?
|
| Syndactyly | 1 | 2016 | 1 | 0.140 |
Why?
|
| Intestines | 1 | 2016 | 4 | 0.140 |
Why?
|
| Retrospective Studies | 5 | 2023 | 2550 | 0.130 |
Why?
|
| Sulfotransferases | 1 | 2015 | 1 | 0.130 |
Why?
|
| Hearing Loss, Bilateral | 1 | 2015 | 2 | 0.130 |
Why?
|
| Mice, Knockout | 3 | 2022 | 15 | 0.130 |
Why?
|
| Transcription Factor TFIID | 1 | 2015 | 1 | 0.130 |
Why?
|
| TATA-Binding Protein Associated Factors | 1 | 2015 | 1 | 0.130 |
Why?
|
| Neurodegenerative Diseases | 1 | 2015 | 3 | 0.130 |
Why?
|
| Malformations of Cortical Development | 1 | 2015 | 1 | 0.130 |
Why?
|
| Hair Cells, Auditory, Outer | 1 | 2015 | 1 | 0.130 |
Why?
|
| MAP Kinase Kinase Kinase 1 | 1 | 2015 | 1 | 0.130 |
Why?
|
| Phosphatidylinositol 3-Kinases | 1 | 2015 | 5 | 0.130 |
Why?
|
| Heart Valve Diseases | 1 | 2015 | 20 | 0.130 |
Why?
|
| Neurofibromatosis 1 | 1 | 2015 | 1 | 0.130 |
Why?
|
| Optic Nerve Neoplasms | 1 | 2015 | 1 | 0.130 |
Why?
|
| Optic Nerve Glioma | 1 | 2015 | 1 | 0.130 |
Why?
|
| PAX6 Transcription Factor | 2 | 2022 | 2 | 0.130 |
Why?
|
| Mice, Transgenic | 2 | 2013 | 3 | 0.130 |
Why?
|
| Ribosomes | 1 | 2015 | 1 | 0.130 |
Why?
|
| RNA Polymerase I | 1 | 2015 | 1 | 0.130 |
Why?
|
| Severity of Illness Index | 3 | 2022 | 476 | 0.130 |
Why?
|
| Trisomy | 1 | 2015 | 3 | 0.130 |
Why?
|
| Chromosome Disorders | 1 | 2015 | 3 | 0.130 |
Why?
|
| Alopecia | 1 | 2015 | 1 | 0.130 |
Why?
|
| Receptor, Endothelin A | 1 | 2015 | 1 | 0.130 |
Why?
|
| Gastrointestinal Diseases | 1 | 2015 | 28 | 0.130 |
Why?
|
| Central Nervous System | 1 | 2014 | 2 | 0.120 |
Why?
|
| Protein Structure, Tertiary | 1 | 2014 | 2 | 0.120 |
Why?
|
| Embryonic Development | 1 | 2014 | 2 | 0.120 |
Why?
|
| Diabetes Complications | 1 | 2015 | 119 | 0.120 |
Why?
|
| United States | 2 | 2020 | 4164 | 0.120 |
Why?
|
| Embryo, Mammalian | 2 | 2016 | 2 | 0.120 |
Why?
|
| Collagen Type XI | 1 | 2014 | 1 | 0.120 |
Why?
|
| Aged, 80 and over | 1 | 2020 | 2003 | 0.120 |
Why?
|
| Insulin | 1 | 2015 | 208 | 0.120 |
Why?
|
| In Situ Hybridization | 2 | 2015 | 6 | 0.120 |
Why?
|
| HEK293 Cells | 3 | 2019 | 8 | 0.120 |
Why?
|
| Retinal Neovascularization | 1 | 2014 | 2 | 0.120 |
Why?
|
| Angiogenesis Inhibitors | 1 | 2014 | 6 | 0.120 |
Why?
|
| Antibodies, Monoclonal, Humanized | 1 | 2014 | 26 | 0.120 |
Why?
|
| Neural Stem Cells | 1 | 2013 | 1 | 0.110 |
Why?
|
| Cell Division | 1 | 2013 | 5 | 0.110 |
Why?
|
| Neuroglia | 1 | 2013 | 3 | 0.110 |
Why?
|
| Base Sequence | 3 | 2019 | 20 | 0.110 |
Why?
|
| Photoreceptor Cells | 2 | 2023 | 2 | 0.110 |
Why?
|
| beta-Galactosidase | 2 | 2010 | 2 | 0.110 |
Why?
|
| Intracellular Signaling Peptides and Proteins | 2 | 2022 | 8 | 0.110 |
Why?
|
| Optics and Photonics | 2 | 2022 | 3 | 0.110 |
Why?
|
| Nuclear Proteins | 2 | 2024 | 11 | 0.110 |
Why?
|
| Dependovirus | 1 | 2012 | 1 | 0.100 |
Why?
|
| Gene Transfer Techniques | 1 | 2012 | 1 | 0.100 |
Why?
|
| cis-trans-Isomerases | 1 | 2012 | 1 | 0.100 |
Why?
|
| Genetic Vectors | 1 | 2012 | 2 | 0.100 |
Why?
|
| Inflammation | 2 | 2022 | 63 | 0.100 |
Why?
|
| Atrophy | 2 | 2022 | 6 | 0.100 |
Why?
|
| Signal Transduction | 3 | 2016 | 30 | 0.100 |
Why?
|
| Clinical Trials as Topic | 1 | 2012 | 133 | 0.100 |
Why?
|
| Algorithms | 2 | 2024 | 241 | 0.100 |
Why?
|
| Diabetes Mellitus | 1 | 2015 | 530 | 0.090 |
Why?
|
| Fundus Oculi | 2 | 2022 | 4 | 0.090 |
Why?
|
| Mice, Inbred ICR | 1 | 2010 | 3 | 0.090 |
Why?
|
| Fluorescent Antibody Technique | 1 | 2010 | 2 | 0.090 |
Why?
|
| Immunohistochemistry | 1 | 2010 | 46 | 0.090 |
Why?
|
| RNA Splicing | 2 | 2019 | 2 | 0.090 |
Why?
|
| Protein Transport | 2 | 2022 | 4 | 0.090 |
Why?
|
| Diagnosis, Differential | 2 | 2021 | 61 | 0.080 |
Why?
|
| Models, Molecular | 2 | 2019 | 4 | 0.080 |
Why?
|
| Consanguinity | 2 | 2019 | 2 | 0.080 |
Why?
|
| Prognosis | 2 | 2020 | 624 | 0.080 |
Why?
|
| COS Cells | 2 | 2019 | 2 | 0.080 |
Why?
|
| Auditory Pathways | 1 | 2007 | 1 | 0.080 |
Why?
|
| Rhombencephalon | 1 | 2007 | 1 | 0.080 |
Why?
|
| Transgenes | 1 | 2007 | 1 | 0.080 |
Why?
|
| Growth Cones | 1 | 2007 | 1 | 0.080 |
Why?
|
| Regulatory Elements, Transcriptional | 1 | 2007 | 1 | 0.080 |
Why?
|
| Paired Box Transcription Factors | 1 | 2007 | 1 | 0.080 |
Why?
|
| Spinal Cord | 1 | 2007 | 2 | 0.080 |
Why?
|
| Conserved Sequence | 1 | 2007 | 2 | 0.080 |
Why?
|
| Transfection | 1 | 2007 | 6 | 0.080 |
Why?
|
| Cell Movement | 1 | 2007 | 5 | 0.080 |
Why?
|
| Repressor Proteins | 1 | 2007 | 13 | 0.070 |
Why?
|
| Prospective Studies | 2 | 2023 | 1314 | 0.070 |
Why?
|
| Facies | 2 | 2017 | 2 | 0.070 |
Why?
|
| Family | 2 | 2019 | 120 | 0.070 |
Why?
|
| Follow-Up Studies | 2 | 2022 | 1269 | 0.070 |
Why?
|
| Neurons | 2 | 2019 | 10 | 0.060 |
Why?
|
| Live Birth | 1 | 2024 | 9 | 0.060 |
Why?
|
| Loss of Function Mutation | 1 | 2024 | 2 | 0.060 |
Why?
|
| Rabbits | 1 | 2024 | 6 | 0.060 |
Why?
|
| Texas | 1 | 2024 | 35 | 0.060 |
Why?
|
| Arylsulfatases | 1 | 2024 | 1 | 0.060 |
Why?
|
| Fibroblasts | 1 | 2024 | 4 | 0.060 |
Why?
|
| Case-Control Studies | 2 | 2018 | 1173 | 0.060 |
Why?
|
| DNA Helicases | 1 | 2024 | 2 | 0.060 |
Why?
|
| Low Density Lipoprotein Receptor-Related Protein-2 | 1 | 2023 | 2 | 0.060 |
Why?
|
| Macaca mulatta | 1 | 2023 | 6 | 0.050 |
Why?
|
| Hexokinase | 1 | 2022 | 1 | 0.050 |
Why?
|
| Evoked Potentials, Visual | 1 | 2022 | 1 | 0.050 |
Why?
|
| Splenomegaly | 1 | 2022 | 1 | 0.050 |
Why?
|
| Melanins | 1 | 2022 | 1 | 0.050 |
Why?
|
| Optic Nerve | 1 | 2022 | 2 | 0.050 |
Why?
|
| Edema | 1 | 2022 | 5 | 0.050 |
Why?
|
| Headache | 1 | 2022 | 14 | 0.050 |
Why?
|
| Pregnancy | 2 | 2021 | 1516 | 0.050 |
Why?
|
| Coloring Agents | 1 | 2022 | 4 | 0.050 |
Why?
|
| Retinal Pigments | 1 | 2022 | 3 | 0.050 |
Why?
|
| Angiography | 1 | 2022 | 12 | 0.050 |
Why?
|
| Epithelial Cells | 1 | 2022 | 6 | 0.050 |
Why?
|
| Gain of Function Mutation | 1 | 2022 | 1 | 0.050 |
Why?
|
| Serum Amyloid A Protein | 1 | 2022 | 1 | 0.050 |
Why?
|
| Amyloidosis | 1 | 2022 | 3 | 0.050 |
Why?
|
| Proteoglycans | 1 | 2022 | 2 | 0.050 |
Why?
|
| Elastin | 1 | 2022 | 1 | 0.050 |
Why?
|
| Retinal Rod Photoreceptor Cells | 1 | 2022 | 1 | 0.050 |
Why?
|
| Tetraspanins | 1 | 2022 | 1 | 0.050 |
Why?
|
| Gene Frequency | 1 | 2022 | 48 | 0.050 |
Why?
|
| Rod Cell Outer Segment | 1 | 2022 | 1 | 0.050 |
Why?
|
| Reproducibility of Results | 1 | 2023 | 399 | 0.050 |
Why?
|
| Paraplegia | 1 | 2021 | 1 | 0.050 |
Why?
|
| Prevalence | 1 | 2024 | 911 | 0.050 |
Why?
|
| Rats | 1 | 2021 | 29 | 0.050 |
Why?
|
| Databases, Factual | 1 | 2023 | 327 | 0.050 |
Why?
|
| Smell | 1 | 2021 | 2 | 0.050 |
Why?
|
| RNA, Messenger | 2 | 2015 | 80 | 0.050 |
Why?
|
| Jagged-1 Protein | 1 | 2021 | 1 | 0.050 |
Why?
|
| Optical Imaging | 1 | 2021 | 1 | 0.050 |
Why?
|
| Age of Onset | 1 | 2021 | 82 | 0.050 |
Why?
|
| DEAD Box Protein 58 | 1 | 2021 | 1 | 0.050 |
Why?
|
| Metacarpus | 1 | 2021 | 1 | 0.050 |
Why?
|
| Receptors, Immunologic | 1 | 2021 | 1 | 0.050 |
Why?
|
| Interferons | 1 | 2021 | 5 | 0.050 |
Why?
|
| Telencephalon | 1 | 2020 | 1 | 0.050 |
Why?
|
| Genome | 1 | 2020 | 4 | 0.050 |
Why?
|
| Penetrance | 1 | 2020 | 4 | 0.050 |
Why?
|
| Genetics, Population | 1 | 2020 | 8 | 0.050 |
Why?
|
| Medical Records | 1 | 2021 | 106 | 0.050 |
Why?
|
| South America | 1 | 2020 | 5 | 0.050 |
Why?
|
| Epiphyses | 1 | 2020 | 1 | 0.050 |
Why?
|
| Pediatricians | 1 | 2020 | 15 | 0.050 |
Why?
|
| Leukocytes | 1 | 2020 | 9 | 0.050 |
Why?
|
| Structure-Activity Relationship | 1 | 2019 | 2 | 0.040 |
Why?
|
| Ophthalmoscopy | 1 | 2019 | 1 | 0.040 |
Why?
|
| HeLa Cells | 1 | 2019 | 4 | 0.040 |
Why?
|
| Synapses | 1 | 2019 | 2 | 0.040 |
Why?
|
| Amino Acid Substitution | 1 | 2019 | 7 | 0.040 |
Why?
|
| Endoplasmic Reticulum | 1 | 2019 | 1 | 0.040 |
Why?
|
| Mitosis | 1 | 2019 | 1 | 0.040 |
Why?
|
| Computational Biology | 1 | 2019 | 28 | 0.040 |
Why?
|
| Genome-Wide Association Study | 1 | 2020 | 252 | 0.040 |
Why?
|
| Gene Expression Profiling | 1 | 2019 | 34 | 0.040 |
Why?
|
| RNA Splice Sites | 1 | 2019 | 1 | 0.040 |
Why?
|
| Refractive Errors | 1 | 2019 | 7 | 0.040 |
Why?
|
| Genetic Loci | 1 | 2019 | 60 | 0.040 |
Why?
|
| Age Factors | 1 | 2022 | 965 | 0.040 |
Why?
|
| Slit Lamp Microscopy | 1 | 2018 | 1 | 0.040 |
Why?
|
| Cornea | 1 | 2018 | 3 | 0.040 |
Why?
|
| DNA, Neoplasm | 1 | 2018 | 21 | 0.040 |
Why?
|
| Quality of Life | 1 | 2022 | 529 | 0.040 |
Why?
|
| Mitochondrial Dynamics | 1 | 2017 | 1 | 0.040 |
Why?
|
| Ataxia | 1 | 2017 | 2 | 0.040 |
Why?
|
| Research Design | 1 | 2020 | 402 | 0.040 |
Why?
|
| Longitudinal Studies | 1 | 2020 | 724 | 0.040 |
Why?
|
| Neuropsychological Tests | 1 | 2017 | 38 | 0.040 |
Why?
|
| Dysbindin | 1 | 2017 | 1 | 0.040 |
Why?
|
| Zebrafish Proteins | 1 | 2016 | 1 | 0.040 |
Why?
|
| Ectoderm | 1 | 2016 | 1 | 0.030 |
Why?
|
| Cell Polarity | 1 | 2016 | 1 | 0.030 |
Why?
|
| Neural Tube | 1 | 2016 | 1 | 0.030 |
Why?
|
| Wnt Signaling Pathway | 1 | 2016 | 1 | 0.030 |
Why?
|
| RNA | 1 | 2016 | 12 | 0.030 |
Why?
|
| Cross-Sectional Studies | 1 | 2020 | 1360 | 0.030 |
Why?
|
| Models, Biological | 1 | 2016 | 32 | 0.030 |
Why?
|
| Proto-Oncogene Proteins | 1 | 2016 | 36 | 0.030 |
Why?
|
| E-Box Elements | 1 | 2015 | 1 | 0.030 |
Why?
|
| Inheritance Patterns | 1 | 2015 | 2 | 0.030 |
Why?
|
| Body Size | 1 | 2016 | 31 | 0.030 |
Why?
|
| Vestibular Nucleus, Lateral | 1 | 2015 | 1 | 0.030 |
Why?
|
| Spiral Ganglion | 1 | 2015 | 1 | 0.030 |
Why?
|
| Basal Bodies | 1 | 2015 | 1 | 0.030 |
Why?
|
| Auditory Threshold | 1 | 2015 | 2 | 0.030 |
Why?
|
| Mice, Mutant Strains | 1 | 2015 | 5 | 0.030 |
Why?
|
| Cell Survival | 1 | 2015 | 8 | 0.030 |
Why?
|
| Down-Regulation | 1 | 2015 | 13 | 0.030 |
Why?
|
| Fibroblast Growth Factors | 1 | 2015 | 11 | 0.030 |
Why?
|
| Charcot-Marie-Tooth Disease | 1 | 2015 | 1 | 0.030 |
Why?
|
| Embryo, Nonmammalian | 1 | 2015 | 1 | 0.030 |
Why?
|
| Microscopy, Confocal | 1 | 2015 | 1 | 0.030 |
Why?
|
| Saccharomyces cerevisiae Proteins | 1 | 2015 | 1 | 0.030 |
Why?
|
| Animals, Genetically Modified | 1 | 2015 | 1 | 0.030 |
Why?
|
| RNA Interference | 1 | 2015 | 1 | 0.030 |
Why?
|
| Mitochondrial Membranes | 1 | 2015 | 1 | 0.030 |
Why?
|
| Microscopy, Electron, Transmission | 1 | 2015 | 2 | 0.030 |
Why?
|
| Muscle Proteins | 1 | 2015 | 5 | 0.030 |
Why?
|
| Neural Crest | 1 | 2015 | 1 | 0.030 |
Why?
|
| Cell Death | 1 | 2015 | 2 | 0.030 |
Why?
|
| Chromosomes, Human, Pair 15 | 1 | 2015 | 7 | 0.030 |
Why?
|
| Zygoma | 1 | 2015 | 1 | 0.030 |
Why?
|
| Endothelin-1 | 1 | 2015 | 1 | 0.030 |
Why?
|
| Morpholinos | 1 | 2015 | 1 | 0.030 |
Why?
|
| Real-Time Polymerase Chain Reaction | 1 | 2015 | 13 | 0.030 |
Why?
|
| Radiography | 1 | 2015 | 41 | 0.030 |
Why?
|
| Intravitreal Injections | 1 | 2014 | 1 | 0.030 |
Why?
|
| Low Density Lipoprotein Receptor-Related Protein-5 | 1 | 2014 | 1 | 0.030 |
Why?
|
| Laser Coagulation | 1 | 2014 | 2 | 0.030 |
Why?
|
| Retinal Hemorrhage | 1 | 2014 | 2 | 0.030 |
Why?
|
| Vascular Endothelial Growth Factor A | 1 | 2014 | 4 | 0.030 |
Why?
|
| Ultrasonography, Prenatal | 1 | 2014 | 8 | 0.030 |
Why?
|
| Bevacizumab | 1 | 2014 | 8 | 0.030 |
Why?
|
| Siblings | 1 | 2014 | 13 | 0.030 |
Why?
|
| Tomography, X-Ray Computed | 1 | 2015 | 208 | 0.030 |
Why?
|
| Polymorphism, Single Nucleotide | 1 | 2015 | 412 | 0.030 |
Why?
|
| Comorbidity | 1 | 2015 | 619 | 0.030 |
Why?
|
| Stilbamidines | 1 | 2007 | 1 | 0.020 |
Why?
|
| Evoked Potentials, Auditory, Brain Stem | 1 | 2007 | 1 | 0.020 |
Why?
|
| Cochlear Nucleus | 1 | 2007 | 1 | 0.020 |
Why?
|
| Mice, Inbred BALB C | 1 | 2007 | 2 | 0.020 |
Why?
|
| Bromodeoxyuridine | 1 | 2007 | 2 | 0.020 |
Why?
|